(Q61980292)
Statements
A Randomized, Placebo-Controlled, Double-Blind, Repeat Dose, Dose Escalation Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Supratherapeutic Doses of GSK189075 Administered for 3 Days in Healthy Volunteers (English)
0 references
April 2007
0 references
12
0 references
18 year
0 references
50 year
0 references